We identified the PA catabolic enzymes SAT1 and SMOX as critical factors in PD, as they influenced α-Syn protein levels and its effects in Drosophila. Our findings provide novel mechanistic insights into a PD model, using α-Syn pathology as a readout to advance biomarker research and set the stage for PA-targeted therapies. Here, SAT1 is linked to Parkinson disease.